English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
The iCMLf Cure Consortium: Driving the Cure of CML - An invitation for global collaboration
February 2026 - The iCMLf is seeking collaborators to join the iCMLf Cure Consortium (iC3), a global, multidisciplinary initiative focused on achieving a cure for CML.
Background
Over the past two decades, tyrosine kinase inhibitors have transformed CML into a manageable disease. Yet for most patients, cure remains elusive. Nearly half of those who achieve deep molecular response relapse after stopping therapy, reflecting the persistence of leukemia stem cells and their supportive microenvironment. Lifelong treatment carries clinical, psychological, and economic burdens and remains inaccessible or unsustainable in many parts of the world. A cure, therefore, is not only a scientific goal, but a global equity imperative.
Global CML Community to Scale Ecuador’s Volcanoes in the iCMLf Climb for a Cure 2026
Physicians, patients and researchers unite at 4,600 metres to advance global CML care
February 26th 2026 – The International CML Foundation (iCMLf) this week launches the iCMLf Climb for a Cure 2026, its flagship global fundraising initiative bringing together physicians, researchers, people living with chronic myeloid leukemia (CML), and supporters for an eight-day high-altitude expedition through Ecuador’s Avenue of the Volcanoes.
Nineteen members of the global CML community will trek to altitudes exceeding 4,600 metres in the foothills of Cotopaxi, one of the world’s highest active volcanoes. The expedition symbolises the resilience, preparation and long-term commitment required to advance CML care and accelerate progress toward a cure.
Reminder: Call for iCMLf Prize nominations – Submission deadline January 31
January 2026 - There is still time to help spotlight excellence in CML research, care, and global access by nominating outstanding individuals for the 2026 iCMLf Prizes.
Each year, these prizes honour visionary scientists, clinicians, and advocates whose lifetime contributions have shaped the global CML landscape. If you have not yet done so, we invite you to submit your nominations for one of the three 2026 iCMLf Prizes:
🥇 The Rowley Prize – For exceptional scientific achievements that have transformed our understanding of CML biology.
🥇 The Goldman Prize – Recognising excellence in advancing clinical practice and improving outcomes for CML patients.
🥇 The iCMLf Prize – Celebrating outstanding efforts to overcome CML treatment challenges in low- and middle-income countries.
Nominations for the 2026 Prizes are closed.
REMINDER: Join us on Tuesday Jan 20th, 14.00 CET for CML Highlights of ASH 2025
January 2026 - This is a friendly reminder to join us for the ‘CML Highlights of ASH 2025’ webinar, the first iCMLf Conversation of 2026, taking place on:
📅 Tuesday, January 20th, 2026
🕐 14:00 Central European Time (CET)
📍 Live webinar on Zoom (45 mins)
Click here for more information and times in other time zones.
If you have not registered yet, you can secure your place here.
Once registered, you’ll receive your Zoom log-in details via Zoom.
Join us for the next iCMLf Conversation: Highlights of ASH 2025
Highlights of the 67th ASH Annual Meeting on January 20th at 14.00 CET
December 2025 - Join us for our next iCMLf Conversation on Tuesday, January 20th 2026 at 14.00 Central European Time where two international experts will review and discuss the most important biological and clinical updates presented during the the 67th ASH Annual Meeting.
Whether you attended the conference or not, this session will summarise biological and clinical highlights and will share the most important takeaways for the CML community.
📅 Date: Tuesday, January 20th
🕑 Time: 14:00 CET
🖥️ Format: Live webinar on Zoom
Honouring excellence in CML: Nominate for the 2026 iCMLf Prizes
December 2025 - Each year, we honour exceptional achievements in CML research and management by recognising lifetime contributions through the three iCMLf Prizes. Since their introduction, these awards have celebrated the work of remarkable scientists, clinicians, and advocates whose leadership, innovation, and dedication have shaped the global CML landscape.
We invite you once again to participate in this tradition by nominating outstanding individuals whose work has transformed our understanding of CML biology, advanced patient management, or improved access to treatment worldwide. Let’s spotlight the visionaries whose contributions continue to inspire the global CML community.
